Top compounds associated with response to CBL


Feature Type Standardized
Nominal ANOVA
mRNA YM-155 CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA foretinib GDSC1000 pan-cancer AAC 0.15 1e-05
mRNA OSI-930 GDSC1000 pan-cancer AAC 0.16 2e-05
mRNA YM-155 GDSC1000 pan-cancer AAC 0.14 7e-05
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 9e-05
mRNA GSK429286A GDSC1000 pan-cancer AAC 0.13 0.0001
mRNA SN-38 GDSC1000 pan-cancer AAC 0.13 0.0002
mRNA Camptothecin GDSC1000 pan-cancer AAC 0.13 0.0003
mRNA RITA CTRPv2 pan-cancer AAC -0.13 0.0004
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0005
Download CSV